Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2234Neoplasms 2041Lung Neoplasms 1099Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 753Carcinoma, Hepatocellular 675Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 435Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 347Brain Neoplasms 332Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 305Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 269Liver Neoplasms 254Hematologic Neoplasms 253Endometrial Neoplasms 253Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Interventions

Genes, fms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Observational × Early Release of Chromogranin A (CgA) × Clear all
NCT06183047 2023-12-27

Predictive Value of Early Changes of Chromogranin A Levels in Patients With Neuroendocrine Tumours Treated With PRRT

Military Institute od Medicine National Research Institute

Completed
38 enrolled

Early Release of Chromogranin A (CgA)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡